EUVIMEDEUVIMED entdecken
Crossref

Immune signatures predict response to house dust mite subcutaneous immunotherapy in patients with allergic rhinitis

Nan Wang, Jia Song, Shi-Ran Sun, Ke-Zhang Zhu, Jing-Xian Li, Zhi-Chao Wang, Cui-Lian Guo, Wen-Xuan Xiang, Yun-Long Tong, Ming Zeng iD, Heng Wang, Xiao-Yan Xu und 2 weitere

Allergy · 2024

DOI: 10.1111/all.16068 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Allergy, 2024. Verfasst von Nan Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Ch…. Hauptthemen laut MEDLINE: Rhinitis, Allergic, Desensitization, Immunologic, Pyroglyphidae, Biomarkers. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Identifying predictive biomarkers for allergen immunotherapy response is crucial for enhancing clinical efficacy. This study aims to identify such biomarkers in patients with allergic rhinitis (AR) undergoing subcutaneous immunotherapy (SCIT) for house dust mite allergy.

Methods

The Tongji (discovery) cohort comprised 72 AR patients who completed 1‐year SCIT follow‐up. Circulating T and B cell subsets were characterized using multiplexed flow cytometry before SCIT. Serum immunoglobulin levels and combined symptom and medication score (CSMS) were assessed before and after 12‐month SCIT. Responders, exhibiting ≥30% CSMS improvement, were identified. The random forest algorithm and logistic regression analysis were used to select biomarkers and establish predictive models for SCIT efficacy in the Tongji cohort, which was validated in another Wisco cohort with 43 AR patients.

Results

Positive SCIT response correlated with higher baseline CSMS, allergen‐specific IgE (sIgE)/total IgE (tIgE) ratio, and frequencies of Type 2 helper T cells, Type 2 follicular helper T (T FH 2) cells, and CD23 + nonswitched memory B (B NSM ) and switched memory B (B SM ) cells, as well as lower follicular regulatory T (T FR ) cell frequency and T FR /T FH 2 cell ratio. The random forest algorithm identified sIgE/tIgE ratio, T FR /T FH 2 cell ratio, and B NSM frequency as the key biomarkers discriminating responders from nonresponders in the Tongji cohort. Logistic regression analysis confirmed the predictive value of a combination model, including sIgE/tIgE ratio, T FR /T FH 2 cell ratio, and CD23 + B SM frequency (AUC = 0.899 in Tongji; validated AUC = 0.893 in Wisco).

Conclusions

A T‐ and B‐cell signature combination efficiently identified SCIT responders before treatment, enabling personalized approaches for AR patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rhinitis, AllergicDesensitization, ImmunologicPyroglyphidaeBiomarkersHumansMaleAnimalsFemaleAdultTreatment OutcomeImmunoglobulin EMiddle AgedYoung AdultAllergensAntigens, DermatophagoidesInjections, SubcutaneousAdolescentPrognosis

Stichwörter der Autor:innen

allergen immunotherapyallergic rhinitisbiomarkerimmune signatureprediction

Substanzen

BiomarkersImmunoglobulin EAllergensAntigens, Dermatophagoides

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Hubei Clinical Research Center for Nasal Inflammatory Diseases, Wuhan, China.
  • Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Department of Otolaryngology-Head and Neck Surgery, China Resources & Wisco General Hospital, Wuhan, China.
  • Institute of Allergy and Clinical Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

ORCID-Profile: Ming Zeng, Zheng Liu

Förderung

  • National Natural Science Foundation of China
  • Fundamental Research Funds for the Central Universities
  • National Key Research and Development Program of China
  • Knowledge Innovation Program of Wuhan-Shuguang Project
  • Key Research and Development Program of Hubei Province

Zitieren

APA

Wang, N., Song, J., Sun, S. R., Zhu, K. Z., Li, J. X., Wang, Z. C., Guo, C. L., Xiang, W. X., Tong, Y. L., Zeng, M., Wang, H., Xu, X. Y., Yao, Y., & Liu, Z. (2024). Immune signatures predict response to house dust mite subcutaneous immunotherapy in patients with allergic rhinitis. Allergy. https://doi.org/10.1111/all.16068

Vancouver

Wang N, Song J, Sun SR, Zhu KZ, Li JX, Wang ZC, et al. Immune signatures predict response to house dust mite subcutaneous immunotherapy in patients with allergic rhinitis. Allergy. 2024. doi:10.1111/all.16068

BibTeX
@article{Wang2024,
  author = {Wang, Nan and Song, Jia and Sun, Shi-Ran and Zhu, Ke-Zhang and Li, Jing-Xian and Wang, Zhi-Chao and Guo, Cui-Lian and Xiang, Wen-Xuan and Tong, Yun-Long and Zeng, Ming and Wang, Heng and Xu, Xiao-Yan and Yao, Yin and Liu, Zheng},
  title = {Immune signatures predict response to house dust mite subcutaneous immunotherapy in patients with allergic rhinitis},
  journal = {Allergy},
  year = {2024},
  doi = {10.1111/all.16068}
}
Kostenlos starten →